Home › Compare › IMEXF vs CL

IMEXF vs CL: Dividend Comparison 2026

IMEXF yields 2000000.00% · CL yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IMEXF wins by $4.879226400974806e+39M in total portfolio value
10 years
IMEXF
IMEXF
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full IMEXF calculator →
CL
CL
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full CL calculator →

Portfolio growth — IMEXF vs CL

📍 IMEXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIMEXFCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IMEXF + CL cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
IMEXF pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMEXF
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
CL
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, IMEXF beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMEXF + CL for your $10,000?

IMEXF: 50%CL: 50%
100% CL50/50100% IMEXF
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

IMEXF
No analyst data
Altman Z
-72.9
Piotroski
1/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+84.9% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMEXF buys
0
CL buys
9
PoliticianChamberTickerTypeAmountDate
John Boozman🏛 Senate$CL▼ Sell$1,001 - $15,0002025-10-09
Ro Khanna🏢 House$CL▼ Sell$1,001 - $15,0002025-10-07
Rick Larsen🏢 House$CL▼ Sell$1,001 - $15,0002025-10-06
Ro Khanna🏢 House$CL▼ Sell$1,001 - $15,0002025-09-29
Julie Johnson🏢 House$CL▼ Sell$1,001 - $15,0002025-09-25
Lisa McClain🏢 House$CL▼ Sell$1,001 - $15,0002025-09-11
Tim Moore🏢 House$CL▼ Sell$1,001 - $15,0002025-09-10
Ro Khanna🏢 House$CL▲ Buy$1,001 - $15,0002025-09-05
Ro Khanna🏢 House$CL▲ Buy$1,001 - $15,0002025-08-26
Lisa McClain🏢 House$CL▲ Buy$1,001 - $15,0002025-08-13
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIMEXFCL
Forward yield2000000.00% ✓4.00%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth0%5% ✓
5-year div CAGR0%5% ✓
Portfolio after 10y$4.879226400974806e+39M$28.0K ✓
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓$899.19
Total dividends collected$4.879195005460081e+39M$6.4K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: IMEXF vs CL ($10,000, DRIP)

YearIMEXF PortfolioIMEXF Income/yrCL PortfolioCL Income/yrGap
1← crossover$200,010,700$200,000,000.00$11,120$420.00+$200.00M → IMEXF
2$3,738,731,768,458$3,738,517,757,009.35$12,357$458.31+$3738731.76M → IMEXF
3$65,315,062,866,930,490$65,311,062,423,938,240.00$13,721$499.76+$65315062866.92M → IMEXF
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$15,227$544.58+$1066400830062625.00M → IMEXF
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$16,885$593.02+$16272182796453826560.00M → IMEXF
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$18,713$645.34+$2.3205424011366188e+23M → IMEXF
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$20,724$701.81+$3.0927990661046884e+27M → IMEXF
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$22,938$762.73+$3.8524105697352695e+31M → IMEXF
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$25,372$828.41+$4.484688260147987e+35M → IMEXF
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$28,047$899.19+$4.879226400974806e+39M → IMEXF

IMEXF vs CL: Complete Analysis 2026

IMEXF — Stock

Imagin Medical Inc. operates as a surgical imaging company focusing on bladder cancer. The company is developing the i/Blue Imaging System to meet the BLC needs of urologists. Imagin Medical Inc. was founded in 1986 and is headquartered in Vancouver, Canada.

Full IMEXF Calculator →

CL — Consumer Staples

CL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in CL shares.

Full CL Calculator →
📬

Get this IMEXF vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMEXF vs SCHDIMEXF vs JEPIIMEXF vs OIMEXF vs KOIMEXF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.